The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

N.I. Kurysheva

Oftal'mologicheskij tsentr Federal'nogo mediko-biologicheskogo agentstva, ul. Gamalei, 15, Moskva, Rossijskaja Federatsija, 123098

L.V. Lepeshkina

Ophthalmological Center of the Federal Medical-Biological Agency of the Russian Federation, A.I. Burnazyan Federal Medical and Biophysical Center of FMBA, 15 Gamalei St., Moscow, Russian Federation, 123098

E.O. Shatalova

Clinics of doctor ShatalovA Naberezhnaja St., Orekhovo-Zuyevo, Russia

Comparative study of factors associated with the progression of primary open-angle and angle-closure glaucoma

Authors:

N.I. Kurysheva, L.V. Lepeshkina, E.O. Shatalova

More about the authors

Journal: Russian Annals of Ophthalmology. 2020;136(2): 64‑72

Views: 1602

Downloaded: 55


To cite this article:

Kurysheva NI, Lepeshkina LV, Shatalova EO. Comparative study of factors associated with the progression of primary open-angle and angle-closure glaucoma. Russian Annals of Ophthalmology. 2020;136(2):64‑72. (In Russ., In Engl.)
https://doi.org/10.17116/oftalma202013602164

Recommended articles:
Diagnosis and clinical features of non-exudative macu­lar neovascularization. Russian Annals of Ophthalmology. 2023;(1):138-146
Modern achievements in the diagnosis and treatment of glaucoma. Russian Annals of Ophthalmology. 2023;(3):96-106
OCT classification of choroidal nevi. Russian Annals of Ophthalmology. 2023;(3):49-62
Age-related changes in human vitreous. Russian Annals of Ophthalmology. 2023;(3):106-111

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.